Sildenafil Citrate (sildenafil) NDC 82804-025

Product information

Brand name (proprietary)

Sildenafil Citrate

Generic name (nonproprietary)

sildenafil

Active ingredients

Sildenafil citrate — 100 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Proficient Rx LP

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 206401

Marketing start

Oct 12, 2018

Listing expires

Dec 31, 2026

Other FDA classes

Phosphodiesterase 5 Inhibitors (Mechanism)

Identifiers

Product ID 82804-025_b9b1d6ee-da42-4ef2-ab93-cd36d7f34150SPL ID b9b1d6ee-da42-4ef2-ab93-cd36d7f34150SPL set ID b9b1d6ee-da42-4ef2-ab93-cd36d7f34150RxCUI 314229UNII BW9B0ZE037UPC 0382804025909

Pharmacologic class

Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482804002530 followed by a unit qualifier and the quantity Copy

Package 82804-0025-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 206401

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.